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CD8aa+ intraepithelial lymphocytes (IELs) are instru-
mental in maintaining the epithelial barrier in the in-
testine. Similar to natural killer cells and other innate
lymphoid cells, CD8aa+ IELs constitutively express
the T-box transcription factor T-bet. However, the
precise role of T-bet for the differentiation or function
of IELs is unknown. Here we show that mice geneti-
cally deficient for T-bet lacked both TCRab+ and
TCRgd+ CD8aa+ IELs and thus are more susceptible
to chemically induced colitis. Although T-bet was
induced in thymic IEL precursors (IELPs) as a result
of agonist selection and interleukin-15 (IL-15) recep-
tor signaling, it was dispensable for the generation
of IELPs. Subsequently, T-bet was required for
the IL-15-dependent activation, differentiation, and
expansion of IELPs in the periphery. Our study re-
veals a function of T-bet as a central transcriptional
regulator linking agonist selection and IL-15 signaling
with the emergence of CD8aa+ IELs.
INTRODUCTION
Intraepithelial lymphocytes (IELs) are primarily thymus-derived
T cells (Eberl and Littman, 2004) that are scattered along the
length of the basolateral epithelial surface. IELs maintain epithe-
lial barrier function (Komano et al., 1995) and initiate the early
response to infection (Mu¨ller et al., 2000) but also regulate the
activation of immune cells (Poussier et al., 2002). IELs comprise
both conventional CD4+ and CD8ab+ T cells (‘‘Type A or induced
IELs’’) and unconventional CD8aa+ T cells (‘‘Type B or natural
IELs’’) (Cheroutre et al., 2011). In contrast to spleen and lymph
nodes, where almost all T cells (>95%) express the ab T cell re-
ceptor (TCR), the intraepithelial compartment of T cells harbors a230 Immunity 41, 230–243, August 21, 2014 ª2014 Elsevier Inc.significant proportion of T cells expressing the gd TCR (50%)
(Goodman and Lefranc¸ois, 1988).
Studies from TCRwild-type (WT) and transgenic mice have re-
vealed that the TCR repertoire of CD8aa+ IELs is oligoclonal and
skewed toward self-recognition because they need high-avidity
TCR interaction with self-antigens during thymic development
(Leishman et al., 2002). TCRab+ CD8aa+ IELs can be selected
by classical and nonclassical MHC class I molecules because
they are completely absent in B2m/ mice but still present in
H2-Kb/H2-Db/ mice (Cheroutre et al., 2011). The earliest
fate-determined thymic progenitors of TCRab+ CD8aa+ IELs
are triple-positive (TP) cells that simultaneously express CD4,
CD8ab, and CD8aa (Gangadharan et al., 2006) as opposed to
double-positive (DP) cells, which express CD4 and CD8ab. In
addition to its ability to bind classical MHC class I molecules,
CD8aa can also interact with the nonclassical MHC class I mole-
cule thymic leukemia antigen (TLA) (Cheroutre et al., 2011).
Upon agonist selection, TP cells become double-negative (DN)
TCRab+ cells that express high levels of CD5 and CD90. At this
stage, DN TCRab+CD5+CD90+NK1.1 thymic IEL precursors
(IELPs) leave the thymus (Gangadharan et al., 2006). Facilitated
by the expression of the gut homing receptors CCR9 (Wurbel
et al., 2001) and a4b7 (Andrew et al., 1996), they then migrate
to the intestinal epithelium to become resident cells that downre-
gulate CD5 and CD90 while upregulating CD8aa (Gangadharan
et al., 2006) and CD103 (Andrew et al., 1996). This homing
pattern is crucial as their survival depends on interleukin-15
(IL-15) that is produced and presented by intestinal epithelial
cells (ECs) (Mortier et al., 2009).
Furthermore, natural IELs express various natural killer (NK)
cell markers that relate them to innate lymphoid cells (ILCs)
(Cheroutre et al., 2011). This innate signature results from a
unique transcriptional program, which is initiated by agonist se-
lection in the thymus (Yamagata et al., 2004). This signature is
not restricted to surface markers but also affects signaling
molecules and transcription factors (TFs). For example, the aryl
hydrocarbon receptor (AhR, encoded by Ahr) is important for
the development of CCR6RORgt+ ILCs (Klose et al., 2013;
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T-bet Regulates Development of CD8aa+ IELsKiss et al., 2011) and CD8aa+ IELs (Li et al., 2011). Moreover, the
T-box TF T-bet is expressed in CD8aa+ IELs and CCR6RORgt+
ILCs. In the latter, T-bet regulates their differentiation into
NKp46+CCR6RORgt+ ILCs (Klose et al., 2013), whereas its
role in CD8aa+ IELs has remained elusive.
In this study, we have investigated the role of the T-box TFs
T-bet and Eomes in the development of IELs. We demonstrate
that the induction of IELPs in the thymus was independent
of T-box TFs. However, the differentiation and expansion of
TCRab+ and TCRgd+ CD8aa+ IELs intrinsically depend on
T-bet, but not Eomes. Therefore, Tbx21/ mice lacked both
TCRab+ and TCRgd+ CD8aa+ IELs in the intestine. T-bet expres-
sion in thymic IELPs was induced as a result of agonist selection
and IL-15 signaling. After induction, T-bet controlled the effects
of IL-15 on IEL development as Tbx21/ thymic IELPs failed to
expand and did not upregulate CD8aa when stimulated with
IL-15. We also show that this T-bet dependent differentiation
program of CD8aa+ IELs was essential to protect mice from
chemically induced colitis. Thus, we have established a previ-
ously unrecognized and nonredundant role of T-bet for the
development of CD8aa+ IELs.
RESULTS
Intraepithelial Lymphocytes Express T-box
Transcription Factors
The T-box TFs T-bet and Eomes are important in the develop-
ment and function of memory T cells (Banerjee et al., 2010),
which share many features with IELs. Therefore, we assessed
the expression of T-bet and Eomes in different IEL populations
(see Figure S1A available online) and compared them with naive
(CD44), central memory (Tcm, CD44+CD62L+), and effector
memory (Tem, CD44+CD62L) CD8 T cell subsets in the spleen
(Figure S1B). IELs were split into TCRab+ CD8ab+, TCRab+
CD8aa+, and TCRgd+ CD8aa+, whereas the two latter ones are
natural IELs and the first represents induced IELs. We excluded
CD4+ IELs, including CD4+CD8aa+ IELs from the analysis,
because these cells are partially the progeny of MHC class II-
restricted CD4 SP thymocytes (Mucida et al., 2013) and there-
fore developmentally distinct from natural IELs. Naive T cells in
the spleen neither expressed Eomes nor T-bet in flow cytometry
analysis (Figures 1A–1D). In contrast, all splenic memory T cells
(CD44+) and virtually all IELs stained positive for T-bet. Eomes
was highly expressed in splenic Tcm cells but low in Tem cells,
whereas it was absent in all IELs and naive T cells (for statistical
analysis, see Figures S1C and S1D). This was further corrobo-
rated by the analysis of EomesGFP/+ mice that showed no
expression of Eomes in thymic IELPs or CD8aa+ IELs (Fig-
ure S1E). We confirmed and extended our data by sorting the
different splenic and IEL T cell populations and subsequent anal-
ysis by quantitative RT-PCR (qPCR). All IELs expressed high
amounts of Tbx21 (Figure 1E; Figure S1F) but lacked expression
of Eomes (Figure 1F; Figure S1G). In addition, similar to Tem
cells, IELs expressed high amounts of the differentiation marker
Prdm1 (encodes for Blimp1) (Figure 1G; Figure S1H) and the
cytokine Ifng (encodes for IFN-g) (Figure 1G; Figure S1I). In line
with their dependency on IL-15 signaling (Mortier et al., 2009)
and similar to splenic memory T cells, CD8aa+ IELs expressed
high Il2rb (Figure 1G; Figure S1J), which encodes for the IL-2Rb chain that is shared by the IL-2 and the IL-15 receptor com-
plex. Confirming previous reports (Li et al., 2011) CD8aa+ IELs
showed the highest expression for Ahr (Figure 1G; Figure S1K)
that could not be detected in naive and central memory T cells.
Thus, CD8aa+ IELs show a transcriptional profile that relates
them closely to Tem cells.
Development of CD8aa+ IELs Intrinsically Depends
on T-bet
Tem cells primarily depend on T-bet for their development,
whereas Tcm cells depend on Eomes (Banerjee et al., 2010).
Hence we next focused on the requirement for T-box TFs in
the development of CD8aa+ IELs. To do this, we used constitu-
tive Tbx21/ and conditional EomesD/D mice (Arnold et al.,
2008), because constitutive Eomes-deficient mice exhibit
embryonic lethality. Because our colony of EomesD/D mice is
on a C57BL/6x129/Sv mixed background, we used Eomesfl/fl
littermate mice as the relevant control for EomesD/Dmice. Corre-
sponding to their respective expression pattern in WT mice (Fig-
ures 1A–1F), T-bet was crucial for both TCRab+ and TCRgd+
CD8aa+ IELs, because these cells were essentially absent in
Tbx21/ mice (Figures 2A and 2B) while they were still present
in EomesD/D mice (Figure 2C and 2D). We also did not detect an
increased number of TCRab+ CD8aa+ T cells at other sites (Fig-
ures S2A and S2B), excluding a migrational defect as the cause
of the observed phenotype. In fact, TCRab+ CD8aa+ and TCRgd+
CD8a+ T cells in the spleen of Tbx21/ were also significantly
reduced (Figures S2A–S2D), indicating that T-bet regulates
the appearance of CD8aa+ T cells at various sites throughout
the body. Immunofluorescence staining of the small intestine
of WT and Tbx21/ mice confirmed that the intraepithelial
compartment of Tbx21/ mice contained primarily CD8ab+
T cells, but not CD8aa+ T cells (Figure 2E).
To test whether T-bet expression has an intrinsic role in
the development of CD8aa+ IELs, we generated mixed bone-
marrow chimeras by lethally irradiating CD45.1 mice and inject-
ing them with CD45.1:CD45.2 Tbx21+/+ or CD45.1:CD45.2
Tbx21/ bone marrow. Examination of these mice 6 weeks
later demonstrated that T-bet was intrinsically required for the
development of both TCRab+ and TCRgd+ CD8aa+ IELs, but
not for CD8ab+ IELs (Figures 2F and 2G; Figures S2E and
S2F). Finally, analysis of the thymi from CD45.1:CD45.2
Tbx21/ mice showed no impaired egress of Tbx21/ IELPs
over WT IELPs (Figures S2E and S2F). This was further corrobo-
rated by the fact that IELPs from Tbx21/ mice showed normal
expression of S1pr1 (encodes for S1P1), which is crucial for S1P1
dependent thymic egress of IELPs (Odumade et al., 2010)
(Figure S2G).
Thus, T-bet is intrinsically required for the development of
CD8aa+ IELs, and T-bet deficiency in IELs does not result in
aberrant peripheral homing or impaired egress from the thymus.
AhR and Microbial Stimuli Are Not Necessary for the
Expression of T-bet in CD8aa+ IELs
An intriguing parallel between CCR6RORgt+ ILCs and CD8aa+
IELs is their shared dependence on T-bet and AhR (Klose et al.,
2013; Li et al., 2011). To better understand this relationship,
we analyzed the CD8aa+ compartment of Ahr/ mice. We
confirmed that Ahr/ mice had reduced numbers of bothImmunity 41, 230–243, August 21, 2014 ª2014 Elsevier Inc. 231
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T-bet Regulates Development of CD8aa+ IELsTCRab+ and TCRgd+ CD8aa+ IELs (Figure 3A); however, the re-
maining cells expressed T-bet amounts similar to WT mice (Fig-
ure 3B). These data argue against a direct transcriptional regula-
tion of T-bet through AhR. Vice versa, the agonist-induced
induction of Ahr in thymic IELPs, which occurs after selection
at the DP stage, was not impaired in Tbx21/ mice (Figure 3C).
Thus, T-bet and AhR do not interact in a simple linear model but
rather control different, yet crucial, aspects of natural IEL devel-
opment or maintenance.
We have shown that the expression of T-bet in CCR6RORgt+
ILCs is partially regulated by the microbial flora (Klose et al.,
2013). A previous report on Myd88/ mice has suggested a
possible role of the microbiota on CD8aa+ IELs by regulating
IL-15 production (Yu et al., 2006). Hence, we analyzed the intra-
epithelial compartment of germ-free (GF) and specific-path-
ogen-free (SPF) mice to unequivocally address the role of the
microbiota in the homeostasis of CD8aa+ IELs. The local cytokine
niche was intact as GF mice showed significantly higher expres-
sion of Il15 in their epithelial compartment, whereas the expres-
sion of Il15ra was unchanged (Figure 3D). We also detected a
significant reduction of TCRab+ CD8ab+ cells in GFmice (Figures
3E and 3F), which was expected, because these cells largely
represent conventional memory T cells (Masopust et al., 2006).
Both TCRab+ and TCRgd+ CD8aa+ IELs were not reduced in
GF mice and thus relatively overrepresented in the intestinal
epithelium. In line with that, the respective T-bet histograms of
SPF and GF mice were virtually superimposable (Figure 3G),
excluding anymajor influence ofmicrobial stimuli on the epithelial
induction of IL-15 and expression of T-bet in CD8aa+ IELs.
Effects of T-bet Expression on Thymic IEL Development
IELs are thymus-derived T cells that progress through a defined
set of stages before they egress from the thymus and migrate
to the intestine (Gangadharan et al., 2006). Hence, we next
focused on the thymic development of TCRab+ CD8aa+ IELs.
Thymic IELPs are DN TCRab+CD5+NK1.1 cells (see Figure S3A
for gating), and comparing thymi from WT and Tbx21/ mice
showed no significant difference in the absolute numbers of
IELPs (Figure 4A). This would argue that T-bet is not required
for IEL commitment but rather for their subsequent differentia-
tion. Intranuclear staining of WT thymi for T-bet supported this
assumption as only a minor population of 4.8% ± 2.5% (n = 18)
IELPs was T-bet+. T-bet+ cells had begun to downregulate CD5
(Figure 4B, upper row) indicating that T-bet expression was a
late-stage event during thymic IEL development as cells, which
are positively selected at the DP stage express high amounts
of CD5 (Figure 4B). To better understand the kinetics of T-bet
expression, we compared thymic IELPs from WT mice with
pre- and postselection DP thymocytes based on the absence
or presence of surface TCRb (Saini et al., 2010), respectively.Figure 1. IELs Express the T-box TF T-bet but Not Eomes
(A and B) Histograms show expression of T-bet (A) or Eomes (B) of the indicated
mice as determined by flow cytometry. Gating strategy is shown in Figures S1A
(C and D) Mean fluorescent intensity (MFI, mean + SD, n = 4) of the data shown in
and S1D.
(E, F, and G) qPCR of the indicated genes determined from cDNA of the indicat
(mean + SD, n = 3). For clarity reasons, statistical analysis is shown in Figures S1
See also Figure S1.T-bet+ cells were CD122+CD69CD5midEGR2lo (Figure 4B),
further supporting the notion that T-bet is induced at a late stage
during thymicdevelopmentof IELs.Becausewehadnoaccess to
TLA tetramers,wewere not able to unequivocally assess the level
of T-bet in TP thymocytes. However, TP thymocytes are among
DP TCRb preselection thymocytes (left column Figure 4B),
whichhardly expressedanyT-bet, especially not thehigh amount
seen in IELPs. Thus, strong induction of T-bet is only seen in a
low percentage of positively selected IELPs. Likewise, thymic
Vg7+ TCRgd+ cells, which are presumably precursors of TCRgd+
CD8aa+ IELs (Bonneville et al., 1988), did not express T-bet and
were not reduced in Tbx21/ mice (Figure S3B-D).
Collectively, these data show that T-bet is not required for
thymic fate decision of CD8aa+ IELs, but rather for their subse-
quent development.
Finally, we investigated whether Tbx21/ IELPs had an
altered phenotype that could have an impact on their develop-
ment. Notably, Tbx21/ IELPs failed to downregulate CD5
and to upregulate CD122 (Figure 4C). In addition, T-bet has
been shown to be a transcriptional repressor of Il7ra (encodes
for CD127) (Powell et al., 2012). In accordance, CD127 expres-
sion remained high in Tbx21/ IELPs. Interestingly, the downre-
gulation of CD69 and upregulation of CD44 in Tbx21/ IELPs
were even more pronounced in Tbx21/ mice, implicating that
T-bet does not regulate all aspects of thymic IEL differentia-
tion (Figure 4C). Collectively, these data show that T-bet can
be induced during thymic development and that it controls key
events of IEL differentiation already in the thymus.
Similar to other intestinal immune cells, CD8aa+ IELs depend
on partially redundant, b7-containing integrins (Wagner et al.,
1996), a4b7 and aEb7 (aE is also known as CD103), as well as
the chemokine receptor CCR9, for their homing to the intestine
(Wurbel et al., 2001). Staining thymic TCRab+ IELP from WT
and Tbx21/ mice we could detect an increase in CD103, no
reduction of CCR9, and only a mild effect on a4b7 expression
arguing against an intestinal homing defect in the absence of
T-bet (Figure S3E).
Tbx21–/– IELPs Home to the Intestine but Fail to
Differentiate and Expand In Vivo
To formally exclude the possibility that a defect in thymic
egress or intestinal homing could account for the absence of
natural IELs in Tbx21/ mice, we transferred thymic IELPs
from WT and Tbx21/ mice into alymphoid C57BL/6 Rag2/
Il2rg/ mice. Four weeks later, we determined the presence of
intestinal IELs. Following the transfer of WT cells, we could
recover high numbers of natural IELs that were primarily
TCRab+CD8aa+CD5T-bet+ cells (Figures 5A–5C, Figure S4A).
Notably, C57BL/6 Rag2/Il2rg/ mice are devoid of any lym-
phocytes and thus lack cryptopatches. Immunofluorescencecell subset of the spleen or the epithelium of the small intestine from C57BL/6
and S1B.
A (C) or B (D). For clarity reasons, statistical analysis is shown in Figures S1C
ed sorted subsets from C57BL/6 mice depicted as n-fold difference of Hprt1
F and S1K. Data are representative of at least two independent experiments.
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Figure 2. Intrinsic Requirement for T-bet in Natural IEL Development
(A and C) Flow cytometry analysis of CD45+CD4 IELs from Tbx21+/+ and Tbx21/ (A) or Eomesfl/fl and EomesD/D mice (C) electronically gated on TCRgd- or
TCRb-positive cells and further analyzed for expression of CD8a and CD8b.
(B and D) Absolute cell numbers (mean + SD) from the experiments described in A (B) and C (D) with n = 4–8 mice per genotype.
(E) Immunofluorescence staining of the small intestine of Tbx21+/+ and Tbx21/ mice for the indicated markers. Representative pictures taken with 1003
magnification are shown.
(F) IELs from the small intestine of bone marrow chimeric mice reconstituted with either bone marrow from CD45.1 Tbx21+/+ and CD45.2 Tbx21+/+ mice or from
CD45.1 Tbx21+/+ and CD45.2 Tbx21/ were analyzed by flow cytometry 6 weeks after transfer. Plots are electronically gated on CD45+CD4TCRgd+ or
CD45+CD4TCRb+ lymphocytes and analyzed for CD8a and CD8b.
(G) Relative cell numbers (mean + SD) of the experiment shown in (F). Relative frequency of CD45.2+ from either Tbx21+/+ or Tbx21/ donors in bone marrow
chimeras are compared (n = 12).
Numbers represent percentage of cells in gates. Data are representative of at least two independent experiments. See also Figure S2.
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Figure 3. AhR and Microbial Stimuli Do Not
Regulate Expression of T-bet in IELs
(A) Dot plots show TCRgd and TCRb expression on
CD45+CD4- IELs from Ahr+/+ and Ahr/ mice and
further analysis for CD8a and CD8b for gd and ab
T cells, respectively. Numbers represent percent-
age of cells in gates. Data are representative of two
independent experiments with a total of six mice
per genotype.
(B) Histograms show T-bet expression by the
indicated cell population from the experiment in (A).
(C) qPCR for Ahr determined from cDNA of sorted
CD45+CD4+CD8a+ (DP) or CD45+CD4CD8a-
TCRb+NK1.1 (IELP) thymocytes from Tbx21+/+
and Tbx21/ mice depicted as n-fold difference
of Hprt1. Experiments were performed twice, one
representative result is shown.
(D) qPCR for Il15 and Il15ra determined from cDNA
of intestinal epithelial cells from SPF control mice
or GF mice depicted as n-fold difference of Hprt1
(n = 12).
(E) Dot plots show TCRgd and TCRb expression
in CD45+CD4 IELs from SPF and GF mice and
further analysis of CD8a and CD8b in ab and gd
T cells, respectively.
(F) Absolute cell numbers (Mean + SD, n = 4–5 per
microbial status) of the experiment as shown in (E).
(G) Histograms show T-bet expression by the
indicated cell populations from the experiment in
(E). Data are representative of two independent
experiments.
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WT IELPs also showed no de novo generation of ‘‘crypto-
patch-like’’ structures (Figure S4B). Hence, thymus-derived
IELPs develop independent of cryptopatches within the intes-
tinal epithelium. In contrast, the transfer of Tbx21/ cells did
not yield any CD8aa+ IELs (Figure 5A). We also detected
only very little numbers of cells that matched the profile of
the injected precursors (TCRab+CD8aaCD5+) after the trans-
fer of Tbx21/ IELPs (Figure 5B). Thus, IELPs in the periphery
cannot expand or differentiate in the absence of T-bet (Figures
5A and 5B). In fact, because IELPs from Tbx21/ mice rarely
downregulated CD5, we argue that T-bet is crucial for this
developmental step (Figures 5D and 5E). Interestingly, we
also found CD8ab+ and CD8ab IELs after transfer of WT
and Tbx21/ IELPs, albeit at much higher numbers after
transfer of WT IELPs (Figures 5A and 5B). The progeny of
WT IELPs had characteristics similar to those of CD8aa IELs,Immunity 41, 230–243such as lack of CD5 (Figures 5C–5E)
and expression of T-bet (data not
shown). Hence thymic IELPs can give
rise to three distinct natural IEL popula-
tions (CD8ab-, CD8aa+, CD8ab+) whose
common denominator is the downregu-
lation of CD5 while uniformly expressing
T-bet.
Together these data are consistent with
a model in which induction of T-bet is not
required for intestinal homing but is
essential for immature IELPs to expandand differentiate into CD8aa+ IELs within the epithelial
compartment.
CD8aa+ IELs Ameliorate Chemically Induced Colitis
It has been shown in the past that TCRab+ CD8aa+ IELs can be
protective in models of T cell-mediated colitis. To test whether
T-bet dependent TCRab+ CD8aa+ IELs could also ameliorate
chemically induced colitis models, we used two complementary
models. First, we transferred thymic IELPs fromWT or Tbx21/
mice into cohoused Rag2/Il2rg/ mice. Six weeks later,
we treated both groups, plus an additional control group, with
DSS. Rag2/Il2rg / mice that had received IELPs from WT
mice showed the fastest recovery after cessation of DSS and
gradually regained weight, albeit this did not reach statistical sig-
nificance (Figure 5F). In contrast, Rag2/Il2rg/ mice that had
received Tbx21/ IELPs showed a tendency to lose weight
after an initial phase of recovery. Detailed microscopic analysis, August 21, 2014 ª2014 Elsevier Inc. 235
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Figure 4. IELPs Develop in Tbx21–/– Mice
(A) Absolute numbers of CD45+CD4CD8a (DN) or CD45+CD4CD8aTCRb+NK1.1 (IELP) thymocytes from Tbx21+/+ and Tbx21/micewith at least tenmice
per genotype. Gating strategy is shown in Figure S3A.
(B) Flow cytometry analysis of the indicated cell populations from the pooled thymi from three mice gated on DP TCRb (preselection), DP TCRb+ (postselection),
or IELP lymphocytes for the indicated markers.
(C) Histograms show comparison of the indicatedmarkers of IELPs from pooled thymi from Tbx21+/+ and Tbx21/mice asmeasured by flow cytometry. Data are
representative of at least three independent experiments. See also Figure S3.
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Rag2/Il2rg/ mice that had received Tbx21/ IELPs was
due to a significant inflammation of the cecum that included
loss of crypts, influx of inflammatory cells, and ulcers (Figure 5G;
Figure S4C). In a second set of experiments we explored the role
of CD8aa+ IELs in a more physiological setting. Tbx21/ mice
are more susceptible to develop severe DSS colitis than WT
mice, which has been linked to the absence of T-bet in the innate
immune system (Garrett et al., 2007). Based on our results, we
were wondering whether the absence of CD8aa+ IELs contrib-
uted to this phenotype. Hence, we reconstituted Tbx21/
mice with CD8aa+ IELs fromWTmice and treated them together
with cohoused Tbx21/ and WT mice with DSS. Indeed,
Tbx21/mice showed the most serious symptoms, exemplified
by accelerated weight loss and inflammation of the colon and
caecum (Figures 5H and 5I; Figure S4D). Reconstitution of
Tbx21/ mice with CD8aa+ IEL rescued the severe phenotype
of Tbx21/ mice. In fact, CD8aa+ IEL reconstituted Tbx21/
mice were clinically and histomorphologically (Figures 5H and236 Immunity 41, 230–243, August 21, 2014 ª2014 Elsevier Inc.5I; Figure S4D) indistinguishable from WT mice. Hence,
CD8aa+ IELs are able to alleviate chemically induced colitis.
Collectively, these experiments emphasize the important
contribution of T-bet-dependent development of CD8aa+ IELs
to intestinal homeostasis.
Agonist Selection Induces the Expression of T-bet in
IELPs
Similar to natural IELs, thymus-derived regulatory T cells (tTregs)
are also selected through high-avidity interactions in the thymus
and as consequence tTreg cells express Helios (Thornton et al.,
2010). In line with this, intranuclear staining revealed that the
great majority of T-bet+ IELPs was also Helios+ (Figure 6A),
further supporting the assumption that these cells are IELPs.
Curiously, around 45% of T-bet IELPs stained negative for He-
lios (Figure 6A), suggesting that these cellsmight not have under-
gone high-avidity agonist selection. Next, we investigated the
direct effects of agonist selection on IELPs by usingmice that ex-
pressed endogenous superantigens. DBA/2 mice express the
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Figure 5. IELPs Require T-bet for Proper Reconstitution of the IEL Compartment
(A) IELPs from the thymus were adoptively transferred in C57BL/6 Rag2/Il2rg/. Four weeks later, CD45+ IELs were analyzed for TCRgd and TCRb expression
and TCRb+ cells subsequently for CD8a and CD8b. Numbers represent percentage of cells in gates.
(B) Absolute cell numbers (mean + SD, n = 4) of the indicated cell subsets from the experiment shown in (A).
(C) Flow cytometry analysis for CD5 and T-bet of TCRab+ CD8aa+ IELs from the experiment in (A).
(D) Histograms show flow cytometry analysis for CD5 expression on TCRab+ CD8ab+ or TCRab+ CD8ab IELs from the experiment in (A).
(E) Percentage (mean + SD, n = 4) of TCRab+ CD8ab+CD5+ and TCRab+ CD8abCD5+ from the experiment shown in (A). Data are representative of two in-
dependent experiments with a total of eight mice per group.
(F and G) Indicated groups of Rag2/Il2rg/mice received 3% DSS in drinking water for 9 days, which was then replaced with normal drinking water. Six days
later, mice were culled and analyzed. Weight curves, given as percentage of initial body weight at the start of treatment (F), pathology score (mean + SD, n = 4–5)
of colon sections (G) as shown in Figure S4C.
(H and I) Four percent DSS in drinkingwater was administered for 6 days to Tbx21+/+, Tbx21/, and Tbx21/mice reconstitutedwithWTCD8aa+ IELs. On day 7,
mice were culled and analyzed. Weight curves, given as percentage of initial body weight at the start of treatment (H), pathology score (mean + SD, n = 4–6) of
colon sections (I) as shown in Figure S4D. See also Figure S4.
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T-bet Regulates Development of CD8aa+ IELssuperantigen Mls-1a that is encoded by the mousemammary tu-
mor virus-7. Mls-1a binds to H2-Ed and induces the deletion of
Vb6-, Vb7-, Vb8.1-, and Vb9-expressing DP cells during thymicselection, and therefore these b chains are virtually absent
from their conventional peripheral T cell repertoire. However,
some of these cells escape negative selection and becomeImmunity 41, 230–243, August 21, 2014 ª2014 Elsevier Inc. 237
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Figure 6. Agonist Selection in the Thymus Induces T-bet
(A) Preselection DPs (DP TCRb), postselection DPs (DP TCRb+), and IELPs from the thymi of C57BL/6 mice were analyzed for Helios and T-bet expression by
flow cytometry.
(B) Flow cytometry analysis for CD5 and T-bet of thymocytes from BALB/c and DBA/2 mice electronically gated on Vb6+ IELPs.
(C) Percentages of Vb6+ IELPs (mean + SD) expressing T-bet from the experiment shown in B (n = 6).
(D) C57BL/6 mice or C57BL/6-OVA mice were lethally irradiated and reconstituted with T cell depleted bone marrow from OT-I mice. Six weeks after recon-
stitution, CD45+ thymocytes were analyzed for expression of CD4 and CD8a, and Va2+ IELPs further for CD5 and T-bet expression by flow cytometry. Results of
one representative out of two independent experiments with a total of n = 8 is shown.
(E and F) Absolute numbers (mean + SD, n = 4) for the indicated cell subsets from one experiment as shown in D.
(G) DP pre-selection thymocytes from OT-I B2m/Rag2/ mice were sorted and incubated with DC and the indicated concentration of SIINFEKL peptide in
RPMI medium. Forty-eight hr after begin of the in vitro culture, and cells were harvested and analyzed for CD4 and CD8a (upper row) or CD8a and CD69 (lower
row) by flow cytometry.
(H) Flow cytometry analysis for T-bet expression by CD8a+CD69 and CD8aCD69+ lymphocytes from the experiment shown in (G). Numbers represent
percentage of cells in gates.
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T-bet Regulates Development of CD8aa+ IELsCD8aa+ IELs, where, for example, Vb6+ cells are overrepre-
sented (Rocha et al., 1991). Analysis of Vb6+ IELPs in DBA/2
and BALB/c mice, which share the haplotype H2d but differ in
Mls-1a expression, showed that superantigen stimulation
induced the expression of T-bet in Vb6+ IELPs in DBA/2 mice
versus Vb6+ IELPs in BALB/c mice (Figures 6B and 6C).
The process of agonist selection can also be mimicked under
experimental conditions by crossing TCR-transgenic mice with
mice that express the cognate antigen for which TCR is specific238 Immunity 41, 230–243, August 21, 2014 ª2014 Elsevier Inc.or by generating mixed bone-marrow chimeras (Leishman et al.,
2002). Hence we generated bone-marrow chimeras by lethally
irradiating C57BL/6-OVA mice (Ehst et al., 2003), which express
a membrane-bound form of ovalbumin, and injected them with
T cell-depleted bone marrow from OT-I mice (OT-I/C57BL/
6-OVA). As a control we used lethally irradiated C57BL/6
mice, which were also injected with bone marrow from OT-I
mice (OT-I/C57BL/6). SP OT-I T cells were largely deleted in
OT-I/C57BL/6-OVA mice (Figure 6D). However, these mice
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T-bet Regulates Development of CD8aa+ IELsshowed increased numbers of DN thymocytes (Figures 6D and
6E). Further analysis of this population revealed that the thymi
of OT-I/C57BL/6-OVA mice had a 6-fold increase in the num-
ber of Va2+T-bet+ IELPs as compared with OT-I/C57BL/6
mice (Figures 6D and 6F). Thus T-bet expression in IELPs is a
result of agonist selection.
An important caveat of using TCR transgenic mice is their early
expression of the TCR during thymocyte development. Hence,
we wanted to further corroborate our in vivo data by performing
in vitro cultures with DP preselection thymocytes from OT-I
B2m/Rag2/mice. In these mice, all DP thymocytes express
the OT-I TCR and cells cannot progress beyond the DP stage
because no functional MHC class I is available for positive
selection (Daniels et al., 2006). We sorted DP preselection thy-
mocytes from OT-I B2m/Rag2/ mice and cultured them
with bone-marrow-derived dendritic cells (DCs) in the presence
of increasing doses of the high-affinity peptide SIINFEKL.
Increasing doses of SIINFEKL induced the downregulation of
CD4 and CD8a on previously DP thymocytes (Figure 6G). This
event was antigen-specific, as those cells that lost CD4 and
CD8a were also CD69 positive, indicating recent T cell receptor
activation (Figure 6G). Intriguingly, cells that became double-
negative for CD4 and CD8a started to express T-bet, which
was clearly visible 48 hr after stimulation (Figure 6H). Because
we did not add any IL-15 to our cultures, this set of data impli-
cates that sole TCR stimulation is sufficient to induce T-bet in
IELPs.
IL-15 Induced Expansion and Differentiation of Thymic
IELPs Is Mediated through T-bet
There is an intricate relationship between IL-15 signaling and
T-bet as mutations, which affect the IL-15 signaling pathway,
show a severe defect in T-bet dependent ILCs and innate-like
T cells (Castillo and Schluns, 2012). Comparison of IELPs from
WT, Il15/, and Tbx21/mice showed that there was no differ-
ence in the absolute number of IELPs (Figure 7A), thus IEL
commitment is independent of thymic IL-15 signaling. Careful
analysis of IELPs that coexpressed T-bet and CD122 revealed
that although these cells were present in Il15/ mice, the
expression of CD122 and T-bet on a per cell basis were strikingly
reduced (Figure 7B) as compared to WT mice. The absolute
numbers of CD122+T-bet+ IELPs of WT and Il15/ mice were
not different due to a 2- to 3-fold increase in thymic cellularity
in Il15/ mice (Figure 7C; Figures S5A and S5B). Collectively,
this would be consistent with a model in which low-level expres-
sion of T-bet is a result of agonist selection (Figure 6H) and that
IL-15 is necessary for its further upregulation.
Culturing IELPs for 12 hr with IL-15 led to a 3-fold increase in
Tbx21mRNA (Figure 7D) further supporting the notion that IL-15
signaling regulates expression of T-bet. Signaling through the
IL-15 receptor complex results in the recruitment and phosphor-
ylation of the signal transducer of activation and transcription
(STAT) 5A/B (Johnston et al., 1995). Accordingly, chromatin
immunoprecipitation (ChIP) analysis of CD8aa+ IELs demon-
strated binding of pSTAT5 to the transcriptional start site (TSS)
of Tbx21 and a reported putative enhancer region12 kilobases
50 of the TSS (Liao et al., 2011), which further strengthens
the direct link between IL-15 signaling and T-bet expression
(Figure S5C).Another transcription factor that is important for the differenti-
ation of CD8aa+ IELs and that can be regulated by IL-15 signaling
in splenic CD8 T cells is Runx3 (Pobezinsky et al., 2012). Further-
more, it has been shown for Th1 cell commitment that Runx3
is induced in a T-bet-dependent manner and cooperatively with
T-bet controls cytokine expression in Th1 cells (Djuretic et al.,
2007). However, we could still detect Runx3 in Tbx21/ IELPs,
and upon stimulation with IL-15 we detected a strong induction
of Runx3 that was independent of T-bet (Figure 7D). To address
the downstream effects of IL-15 mediated T-bet induction, we
sorted IELPs from the thymi ofWTandTbx21/miceand treated
them for 7 days with titrated doses of IL-15. This treatment re-
sulted in a dose-dependent expansion of IELPs that completely
required T-bet because IELPs from Tbx21/ mice failed to
expand under these conditions (Figure 7E). For example, under
maximum stimulation with 100 ng/ml IL-15, we measured a
6-fold increase in absolute cell numbers (Figure 7E) and the
majority of cells were CD8aa+, while some remained negative
for CD8aa and CD8ab and others expressed the CD8ab heter-
odimer (Figure 7F). Nevertheless nearly all WT cells were
CD5T-bet+ at the end of the culture and thus shared the
peripheral phenotype of natural IELs (Figure 7G). In contrast,
IELPs from Tbx21/ mice showed no signs of activation under
the influence of IL-15. They did not proliferate (Figure 7E) and
showed only weak upregulation of CD8a or CD8b (Figure 7F).
The T-bet-dependent maturation of IELPs was intriguing as
thymic IELP development also depends on TGF-b (Konkel
et al., 2011), which is a known inhibitor of T-bet in Th1 cell dif-
ferentiation (Gorelik et al., 2002; Huss et al., 2010). Accordingly,
IELP in vitro culture with the addition of TGF-b demonstrated
that TGF-b inhibits the induction of T-bet in IELPs (Figure S5D).
As a direct consequence, IELPs failed to differentiate and
expand into CD8aa+ IELs (Figures S5E and S5F). Thus,
TGF-b and T-bet must act at different stages during early IEL
development.
Finally, we explored whether IL-15 would have similar effects
on T-bet expression in thymic IELPs in vivo. We hypothesized
that limited IL-15 availability in the thymus might contribute to
the low percentage of T-bet+ IELPs in the thymus. To test this,
we treated mice with IL-15-IL-15Ra complexes (Stoklasek
et al., 2006), which results in the expansion of CD8+ T cells,
NKT cells, and NK cells. The treatment of WT mice with IL-15-
IL-15Ra complexes led to an increase of T-bet+ IELPs as
compared to untreated controls. In addition, we also detected
an increase in a population of IELPs with exceptionally high
levels of T-bet (Figure 7H).
One of the effects of IL-15 in innate and innate like immune
cells is the protection from apoptosis. Hence ll15/mice, which
overexpress antiapoptotic molecules (Bcl-2, Mcl-1, Bcl-xL), can
partially restore the numbers but not function of NK cells and
IELs (Nakazato et al., 2007). However overexpression of Bcl-2
in Tbx21/ mice (Tbx21/Bcl2Tg) did not restore CD8aa+ IEL
numbers, suggesting that T-bet provides additional nonsurvival
signals for the development of CD8aa+ IELs (Figures S5G and
S5H). Collectively, the data presented so far are consistent
with a model in which agonist selection induces low levels of
T-bet, which are further bolstered by IL-15 signaling. In turn,
T-bet regulates the IL-15-mediated differentiation and expansion
of IELPs.Immunity 41, 230–243, August 21, 2014 ª2014 Elsevier Inc. 239
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Figure 7. IL-15 Regulates T-bet Expression in IELs
(A and C) Absolute cell numbers (mean + SD) of the indicated cell populations from the thymi of the indicatedmouse strains with a total of n = 6mice per genotype;
not applicable (n.a.).
(B) Thymic IELPs from C57BL/6, Il15/, or Tbx21/ were analyzed by flow cytometry for expression of CD122 and T-bet. T-bet gate is set according to IELPs
from Tbx21/ mice.
(D) Sorted IELPs from the pooled thymi of Tbx21+/+ and Tbx21/ mice were cultivated in RPMI medium and stimulated with IL-15 (100 ng/ml) for 12 hr. Gene
expression was determined by qPCR from cDNA and depicted as n-fold difference of Hprt1.
(E) In vitro culture of sorted IELPs from the pooled thymi (n = 5 per strain) of Tbx21+/+ and Tbx21/ mice. Absolute cell numbers in dependence of IL-15
concentration were determined after 7 days of culture in RPMI supplemented with titrated doses of IL-15.
(F) Flow cytometry analysis for CD8a and CD8b after 7 days in vitro culture with 100 ng/ml IL-15 of sorted IELPs from the thymi of Tbx21+/+ and Tbx21/mice as
depicted in (E).
(G) Flow cytometry analysis for CD5 and T-bet expression of the indicated cell subsets cultivated for 7 days in supplementedRPMImedium and IL-15 at 100 ng/ml
from the experiment in (F).
(H) C57BL/6mice (n = 4) were treatedwith IL-15-IL15Ra complexes. Controlmice received PBS. Forty-eight hr after treatment, thymocytes were analyzed by flow
cytometry. Dot plots were electronically gated on IELPs and further analyzed for CD5 and T-bet expression.
Numbers represent percentage of cells in gates. Data are representative of two (D and H) or three (E–G) independent experiments. See also Figure S5.
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In this study, we have shown that T-bet is a key transcrip-
tion factor that directs the development of both TCRab+ and
TCRgd+ CD8aa+ IELs. T-bet is induced as a result of agonist
selection and IL-15 signaling in IELPs and in turn is required for
the further differentiation and expansion in response to IL-15.
Thus, T-bet is a developmental switch that integrates two path-
ways, which are essential for CD8aa+ IEL development.
TCRab+ CD8aa+ IELs are derived from thymic IELPs that are
a result of strong agonist selection in the thymus (Gangadharan
et al., 2006; Leishman et al., 2002). Strong agonist selection
also induces the expression of the Ikaros family TF Helios, which
has been associated with thymocytes that are either positively
selected to develop into tTreg cells (Thornton et al., 2010)
or negatively selected (Daley et al., 2013). However, some240 Immunity 41, 230–243, August 21, 2014 ª2014 Elsevier Inc.autoreactive thymocytes cells do survive negative selection
and will become thymic IELPs of CD8aa+ IELs (Pobezinsky
et al., 2012). Thus, we were surprised to see that not all DN
TCRab+CD5+CD90+NK1.1, an operative definition of IELPs,
expressed Helios. This would imply that only Helios+ cells within
this gate have received a strong TCR stimulus during selection
and that Helios cells are not bona fide IELPs. The fact that
T-bet+ IELPs were positive for Helios strongly argued that Helios
was not downregulated during thymic IEL development and
thus, Helios cells unlikely represent an intermediate stage of
thymic IEL development.
The fact that TGF-b represses T-bet during TCRab+ IELPs dif-
ferentiation might be counter-intuitive at first, because both fac-
tors are essential for IEL development. However, it is important
to note that the thymic phenotype of Tgfb1/ and Tbx21/
is markedly different. The major effect of TGF-b on IEL
Immunity
T-bet Regulates Development of CD8aa+ IELsdevelopment in vivo is the protection of thymic TCRab+ IELPs
from accelerated cell death and thus Tgfb1/ mice have a se-
vere reduction of IELPs, which is in contrast to Tbx21/ mice
(Konkel et al., 2011). Moreover the expression of CD122 and
CD127 in thymic TCRab+ IELPs are not affected by the absence
of TGF-b signaling, whereas in Tbx21/mice these known T-bet
targets are down- and upregulated, respectively. Thus, it is most
likely that TGF-b and T-bet act at sequential stages during IEL
development but that TGF-b has no direct effect on the expres-
sion of T-bet during early TCRab+ IEL development. Once
induced, T-bet expression becomes resistant to TGF-bmodula-
tion as has been shown for differentiated Th1 cells (Gorelik et al.,
2002; Huss et al., 2010), and which explains the high level of
T-bet in all IELs (Figure 1), irrespective of the constitutive expres-
sion of intestinal TGF-b.
Beside CD8aa+ IELs, other innate (NK cells [Townsend et al.,
2004], CCR6RORgt+ ILCs [Klose et al., 2013], ILC1s [Klose
et al., 2014]) and innate-like lymphocytes (NKT cells [Townsend
et al., 2004]) depend on T-bet for their development and effector
function. A common feature among these cells is that T-bet is
not a prerequisite for lineage commitment of these cells but
rather acts after fate-decision has been made. Differentiation
and expansion are cardinal features of IL-15’s action on NKT
cells (Gordy et al., 2011) and CD8aa+ IELs. We have now pro-
vided compelling evidence that these similarities are the result
of their shared dependence on T-bet, which links IL-15 with dif-
ferentiation and expansion in these cell types.
The peripheral in vivo development of IELs can be recapitu-
lated in vitro by stimulating thymic IELPs with IL-15 without
additional TCR stimulation (Gangadharan et al., 2006). We have
shown that this differentiation and expansion is completely regu-
lated by T-bet as IELPs from Tbx21/ mice neither differentiate
nor expand under these conditions and remain CD5+CD8aa.
In vivo thymic IL-15 is dispensable for IEL development as
transplantation of thymi from Il15/ mice (Lai et al., 2008) into
nude mice or transgenic overexpression of IL-15Ra, restricted
to the intestine of Il15ra/ mice (Ma et al., 2009), can rescue
IEL development. Thus the upregulation of T-bet in5%of IELPs
as detected in WTmice is not a pivotal step for thymic IEL devel-
opment, which is further corroborated by the normal develop-
ment of thymic Vg7+ TCRgd+ cells in Tbx21/ mice. This, in
conjunction with the fact that thymic IL-15 might be limited,
strongly suggests that the majority of IELPs upregulate T-bet
after theyhome to the intestinal epitheliumand respond toepithe-
lial cell derived IL-15. However, IL-15 is not only necessary for the
development of IELs but also for their maintenance as transfer
of WT IELs into Il15/ mice or in vitro culture in the absence of
IL-15 leads to their demise (Lai et al., 2008). IL-15 presumably
acts through activation and translocation of pSTAT5A/B to the
Tbx21 locus, which has already been shown for CD4+ Th1 (Liao
et al., 2011) and CD8+ memory T cells (Grange et al., 2013).
Although notoriously associated with proinflammatory Th1
responses, recent years have gathered evidence that T-bet
plays an important role in regulating immune homeostasis at
the epithelial barrier. Transfer of T-bet-dependent TCRab+
CD8aa+ IELs inhibits colitis in immunodeficient mice that receive
CD4+CD45RBhi T cells (Poussier et al., 2002). In addition,
Tbx21/ and Ahr/ mice that both lack natural IELs develop
more severe colitis upon treatment with DSS (Garrett et al.,2007; Li et al., 2011). Finally, mice with a combined deficiency
of Rag2 and Tbx21, i.e., mice, which lack an adaptive immune
system and expression of T-bet in the remaining innate immune
cells, spontaneously develop colitis (Garrett et al., 2007). Thus,
T-bet regulates innate and adaptive immune cells that are vital
for controlling immune responses at the epithelial barrier.
Regardless of that, T-bet is also expressed in effector T cells
that are involved in inflammatory bowel disease (IBD) (Neurath
et al., 2002) and therefore drugs are designed that interfere
with upstream signals or downstream targets of T-bet. However
the fact that proinflammatory as well as anti-inflammatory im-
mune cells depend on T-bet suggests that therapeutic interven-
tions, which potentially repress T-bet (Sandborn et al., 2012)
or affect the migration of natural IELs, might be deleterious in
circumstances of IBD.
Finally, our results add to previous reports that showed that
T-bet, beside its role in Th1 responses, regulates the develop-
ment and function of a variety of innate and innate-like immune
cells. It is evident that the effects of T-bet must be tightly
controlled and fine-tuned in each cell type, but how this is imple-
mented is currently unknown. Therefore, the future challenge will
be to understand the transcriptional context within which a single
TF is acting in order anticipate the net outcome of their combined
actions. The development of such algorithmsmight pave theway
for new therapeutic interventions.
EXPERIMENTAL PROCEDURES
Mouse Strains
Detailed information about WT and mutant mouse strains is listed in the
Supplemental Experimental Procedures. Mice were kept under SPF condi-
tions and the local animal care committees approved animal experiments.
Isolation of IELs, Thymocytes, or Splenocytes
Small intestineswere removed, Peyer’s patcheswere eliminated, and the small
intestinewasopened longitudinally andwashed in ice coldPBS.Dissociation of
epithelial cells was performed at 37C in HBSS containing 1 mM DTT and
10 mM HEPES two times for 20 min. After each step, samples were vortexed
vigorously and filtered through a 70 mm cell strainer. Lymphocytes were en-
riched by Percoll gradient centrifugation. Thymus or spleen were removed
andmashed through a 70 mmcell strainer to obtain single-cell suspensions. Af-
ter centrifugation, erythrocytes were removed by incubation in lysis buffer.
DSS Colitis
Rag2/Il2rg/ mice were reconstituted with IELPs from Tbx21+/+ or
Tbx21/mice. After 6 weeks, mice DSS colitis was induced by administering
3%DSS (w/v) (MW ca. 40000 Sigma-Aldrich), which was replaced with normal
drinking water after 9 days.
For in vivo transfer of natural IELs, 20 3 106 enriched CD8aa+ IELs from
C57BL/6WTmice were injected into Tbx21/mice. Three days after adoptive
transfer, mice received 4% DSS in the drinking water as described (Garrett
et al., 2007).
Histology and Pathology Assessment
Indicated parts of the intestine were removed, opened longitudinally and
cleaned by washing in ice-cold PBS. A piece of the tissue was fixed in 4%
PFA on ice for 2 hr. Afterward, the tissue was washed three times in ice-cold
PBS before rehydrating the tissue in 30% (w/v) sucrose/phosphate buffer
overnight. Tissue samples were embedded in O.C.T. Compound (Tissue-
Tek) and snap-frozen with liquid nitrogen. Cryostat sections of 8 mm thickness
were collected on frosted glass slides and dried at 37C for 3 hr. Immunofluo-
rescence slides were rehydrated in PBS and blocked with 10% BSA (Sigma-
Aldrich). Slides were incubated with antibodies against CD8a, CD8b, or
CD3, washed, and counterstained with DAPI. For histological assessment ofImmunity 41, 230–243, August 21, 2014 ª2014 Elsevier Inc. 241
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T-bet Regulates Development of CD8aa+ IELspathology in DSS-treatedmice, slides were stained with hematoxilin and eosin
(H&E) and the following parameters were evaluated: Loss of crypts: none (0),
scattered (1), densely scattered (2), enlarged (3), continuous (4); ulcerations:
none (0), scattered (1), enlarged (2); infiltration: none (0), locally limited (1),
continuous (2). Final pathology score was determined by adding the values
of all three parameters.
Statistical Analysis
p value of data sets was determined by unpaired two-tailed Student’s t test
with 95% confidence interval. If equal variances between the groups could
not be assumed, Welch’s correction of the t test was applied. All statistical
tests were performed with Graph Pad Prism V4 software. (*p < 0.05; **p <
0.01 and ***p < 0.001; n.s., not significant).
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Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
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